Novartis India Ltd
company logo

Novartis India Ltd

Novartis India Share Price

Pharmaceuticals
Small Cap

-

0 (0%)

Start Investing in Novartis India Ltd

*By signing up you agree to our Terms and Conditions

Novartis India Ltd Performance

-

-

-

-


-

-

-

-

-

Novartis India Ltd Fundamentals

2,664.75Cr

30.49

3.65

0.02

35.40

2.32%

295.35

i buttonClick here to know more about Fundamentals

Novartis India Ltd Financials

Novartis India Ltd Financialsright-arrow

Novartis India Ltd Shareholding Pattern

Novartis India Ltd Delivery and Volume

About Novartis India Ltd

Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947. The Company is focused on manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal he

-

1947

NOVARTIND

NameDesignation
C SnookChairman (Non-Executive)
Sandra MartryesIndependent Director
SANKER PARAMESWARANIndependent Director
Shilpa JoshiWhole Time Director & CFO
Chandni MaruCompany Sec. & Compli. Officer
Gira SardesaiIndependent Director
Falin MajmudarWhole Time Director
News and Events...

Similar Stocks

What's Trending

View All
View All

Novartis India Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Novartis India Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Novartis India Ltd's share price is ₹672.25 as of 2024-11-04.
Novartis India Ltd's P/E ratio is 30.49 times as of 2024-11-04.
Novartis India Ltd's most recent financial reports indicate a price-to-book ratio of 3.65, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Novartis India Ltd's market capitalization is ₹2664.75 Cr as on 2024-11-04.
The current financial records of Novartis India Ltd show a 11.21% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Novartis India Ltd's most recent financial filings, the company has a total asset value of ₹722.5, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Novartis India Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Novartis India Ltd's 52-week high and low as of 2024-11-04 are ₹698.2 and ₹668.35, respectively.